Growth at Reasonable Price
Results
5
1 new
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KURN New | CHF 22.66 | 14.4% | -24.6% | CHF 928.9m | CHF 34.00 | 448.9 | 61.1% | n/a | Pharmaceuticals & Biotech | ||
NWRN | CHF 11.66 | -1.9% | 69.2% | CHF 245.5m | CHF 47.48 | 13.6 | 50.2% | n/a | Pharmaceuticals & Biotech | ||
LMN | CHF 13.05 | 0.4% | -19.7% | CHF 143.2m | CHF 19.37 | 12.8 | 22.7% | 2.9% | Consumer Services | ||
CICN | CHF 117.40 | -1.3% | -41.9% | CHF 528.0m | CHF 169.20 | 34.6 | 38.8% | 0% | Tech | ||
RIEN | CHF 3.04 | 4.5% | -95.1% | CHF 410.6m | CHF 3.40 | 0.4 | 102.7% | 0% | Capital Goods |
Page 1 of 1